The Association between Four Genetic Variants in MicroRNAs (rs11614913, rs2910164, rs3746444, rs2292832) and Cancer Risk: Evidence from Published Studies

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  He, Bangshun ^a   Pan, Yuqin ^a   Cho, William C ^b   Xu, Yeqiong ^a   Gu, Ling ^a   Nie, Zhenglin ^a   Chen, Liping ^a   Song, Guoqi ^a   Gao, Tianyi ^a   Li, Rui ^a   Wang, Shukui ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b QUEEN ELIZABETH HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CYTOSINE; GUANINE; MICRORNA; THYMINE;

ALLELE; ARTICLE; ASIAN; CANCER RISK; CANCER SUSCEPTIBILITY; COLORECTAL CANCER; CONTROLLED STUDY; ESOPHAGUS CANCER; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; LIVER CELL CARCINOMA; LUNG CANCER; META ANALYSIS (TOPIC); POPULATION BASED CASE CONTROL STUDY; POPULATION GENETICS; PROSTATE CANCER; RISK ASSESSMENT; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; UTERINE CERVIX CANCER; VALIDATION STUDY;

ALLELES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICRORNAS; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK;

EID: 84869104262     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049032     Document Type: Article

References (31)

1. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
2. Berezikov E, Guryev V, van de Belt J, Wienholds E, Plasterk RH, et al. (2005) Phylogenetic shadowing and computational identification of human microRNA genes. Cell 120: 21-24.
3. Calin GA, Croce CM, (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866.
4. Cho WC, (2010) MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int J Biochem Cell Biol 42: 1273-1281.
5. Cho WC, (2010) Recent progress in genetic variants associated with cancer and their implications in diagnostics development. Expert Rev Mol Diagn 10: 699-703.
6. Ryan BM, Robles AI, Harris CC, (2010) Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer 10: 389-402.
7. Xu W, Xu J, Liu S, Chen B, Wang X, et al. (2011) Effects of common polymorphisms rs11614913 in miR-196a2 and rs2910164 in miR-146a on cancer susceptibility: a meta-analysis. PLoS One 6: e20471.
8. Horikawa Y, Wood CG, Yang H, Zhao H, Ye Y, et al. (2008) Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma. Clin Cancer Res 14: 7956-7962.
9. Christensen BC, Avissar-Whiting M, Ouellet LG, Butler RA, Nelson HH, et al. (2010) Mature microRNA sequence polymorphism in MIR196A2 is associated with risk and prognosis of head and neck cancer. Clin Cancer Res 16: 3713-3720.
10. Handoll HH, (2006) Systematic reviews on rehabilitation interventions. Arch Phys Med Rehabil 87: 875.
11. Midgette AS, Wong JB, Beshansky JR, Porath A, Fleming C, et al. (1994) Cost-effectiveness of streptokinase for acute myocardial infarction: A combined meta-analysis and decision analysis of the effects of infarct location and of likelihood of infarction. Med Decis Making 14: 108-117.
12. Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
13. Hoffman AE, Zheng T, Yi C, Leaderer D, Weidhaas J, et al. (2009) microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis. Cancer Res 69: 5970-5977.
14. Dou T, Wu Q, Chen X, Ribas J, Ni X, et al. (2010) A polymorphism of microRNA196a genome region was associated with decreased risk of glioma in Chinese population. J Cancer Res Clin Oncol 136: 1853-1859.
15. Srivastava K, Srivastava A, Mittal B, (2010) Common genetic variants in pre-microRNAs and risk of gallbladder cancer in North Indian population. J Hum Genet 55: 495-499.
16. George GP, Gangwar R, Mandal RK, Sankhwar SN, Mittal RD, (2011) Genetic variation in microRNA genes and prostate cancer risk in North Indian population. Mol Biol Rep 38: 1609-1615.
17. Mittal RD, Gangwar R, George GP, Mittal T, Kapoor R, (2011) Investigative role of pre-microRNAs in bladder cancer patients: a case-control study in North India. DNA Cell Biol 30: 401-406.
18. Xu T, Zhu Y, Wei QK, Yuan Y, Zhou F, et al. (2008) A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma. Carcinogenesis 29: 2126-2131.
19. Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR, et al. (2008) Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci U S A 105: 7269-7274.
20. Okubo M, Tahara T, Shibata T, Yamashita H, Nakamura M, et al. (2010) Association between common genetic variants in pre-microRNAs and gastric cancer risk in Japanese population. Helicobacter 15: 524-531.
21. Zhou F, Zhu H, Luo D, Wang M, Dong X, et al. (2012) A Functional Polymorphism in Pre-miR-146a Is Associated with Susceptibility to Gastric Cancer in a Chinese Population. DNA Cell Biol 31: 1290-1295.
22. Zhou B, Wang K, Wang Y, Xi M, Zhang Z, et al. (2011) Common genetic polymorphisms in pre-microRNAs and risk of cervical squamous cell carcinoma. Mol Carcinog 50: 499-505.
23. Xiang Y, Fan S, Cao J, Huang S, Zhang LP, (2012) Association of the microRNA-499 variants with susceptibility to hepatocellular carcinoma in a Chinese population. Mol Biol Rep 39: 7019-7023.
24. Hu Z, Chen J, Tian T, Zhou X, Gu H, et al. (2008) Genetic variants of miRNA sequences and non-small cell lung cancer survival. J Clin Invest 118: 2600-2608.
25. Zhan JF, Chen LH, Chen ZX, Yuan YW, Xie GZ, et al. (2011) A functional variant in microRNA-196a2 is associated with susceptibility of colorectal cancer in a Chinese population. Arch Med Res 42: 144-148.
26. Li XD, Li ZG, Song XX, Liu CF, (2010) A variant in microRNA-196a2 is associated with susceptibility to hepatocellular carcinoma in Chinese patients with cirrhosis. Pathology 42: 669-673.
27. Wang F, Ma YL, Zhang P, Yang JJ, Chen HQ, et al. (2012) A genetic variant in microRNA-196a2 is associated with increased cancer risk: a meta-analysis. Mol Biol Rep 39: 269-275.
28. Chu H, Wang M, Shi D, Ma L, Zhang Z, et al. (2011) Hsa-miR-196a2 Rs11614913 polymorphism contributes to cancer susceptibility: evidence from 15 case-control studies. PLoS One 6: e18108.
29. Qiu LX, Wang Y, Xia ZG, Xi B, Mao C, et al. (2011) miR-196a2 C allele is a low-penetrant risk factor for cancer development. Cytokine 56: 589-592.
30. Qi P, Dou TH, Geng L, Zhou FG, Gu X, et al. (2010) Association of a variant in MIR 196A2 with susceptibility to hepatocellular carcinoma in male Chinese patients with chronic hepatitis B virus infection. Hum Immunol 71: 621-626.
31. Tano K, Mizuno R, Okada T, Rakwal R, Shibato J, et al. (2010) MALAT-1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility-related genes. FEBS Lett 584: 4575-4580.